导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.24% | 350/1050 |
| 近一周 | 0.11% | 64/1104 |
| 近一月 | -5.35% | 689/1102 |
| 近一季 | 20.98% | 31/1092 |
| 近半年 | 14.51% | 200/1070 |
| 近一年 | -8.64% | 738/1018 |
| 近两年 | 38.98% | 606/926 |
| 近三年 | 24.10% | 449/833 |
| 成立以来 | 85.99% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.98% 818/1070 |
9.82% 544/1101 |
- - |
- - |
| 2025 | 10.92% 818/1065 |
8.49% 199/1014 |
2.49% 467/1038 |
16.91% 698/1050 |
-14.67% 979/1065 |
| 2024 | 1.83% 529/1011 |
-1.63% 406/960 |
-2.95% 503/983 |
13.29% 362/991 |
-5.84% 720/1011 |
| 2023 | -4.34% 187/952 |
6.02% 253/880 |
-1.55% 273/895 |
-7.13% 438/915 |
-1.31% 187/952 |
| 2022 | -20.29% 334/867 |
-10.71% 124/773 |
-8.94% 769/806 |
-17.92% 706/845 |
19.43% 20/867 |
| 2021 | -6.94% 448/740 |
-0.81% 188/580 |
24.98% 92/659 |
-10.25% 516/704 |
-16.36% 695/740 |
| 2020 | 91.20% 54/554 |
16.51% 16/419 |
38.81% 34/466 |
6.35% 336/517 |
11.17% 329/554 |
| 2019 | 49.83% 149/410 |
24.39% 749/1146 |
3.53% 90/1228 |
11.22% 94/390 |
4.60% 351/410 |
| 2018 | -18.93% 58/349 |
- - |
0.61% 58/990 |
-8.86% 696/1000 |
-18.32% 972/1080 |
| 2017 | 4.61% 158/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 长盛医疗量化股票A VS. 东吴新产业精选股票A(580008) |